Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors. (2nd April 2016)
- Record Type:
- Journal Article
- Title:
- Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors. (2nd April 2016)
- Main Title:
- Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
- Authors:
- Nanegrungsunk, Danop
Apaijai, Nattayaporn
Yarana, Chontida
Sripetchwandee, Jirapas
Limpastan, Kriengsak
Watcharasaksilp, Wanarak
Vaniyapong, Tanat
Chattipakorn, Nipon
Chattipakorn, Siriporn C - Abstract:
- Abstract : Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effects of both drugs on mitochondria isolated from human brain tumors have not been thoroughly investigated. This study determined the direct effects of TMZ and BEV as well as the neurotoxic condition (calcium overload), on the function of mitochondria and compared these effects on mitochondria isolated from low- and high-grade human brain tumors. Methods: Mitochondria were isolated from either low- or high-grade human primary brain tumors. Calcium overload conditions (100 or 200 μM), TMZ (300 μM), and BEV (2 mg/mL) were applied to isolated mitochondria from low- and high-grade brain tumors. Following the treatment, mitochondrial function, including reactive oxygen species production, membrane potential changes, and swelling, were determined. The mitochondrial morphology was also examined. Results: In calcium overload conditions, mitochondrial dysfunction was only found to have occurred in low-grade tumors. In TMZ and BEV treatment, BEV, rather than TMZ, caused greater membrane depolarization and mitochondrial swelling in both grades of brain tumors. Conclusions: TMZ and BEV can directly cause the dysfunction of mitochondria isolated from human brain tumors. However, BEV has a greater ability to disturb mitochondrial function inAbstract : Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effects of both drugs on mitochondria isolated from human brain tumors have not been thoroughly investigated. This study determined the direct effects of TMZ and BEV as well as the neurotoxic condition (calcium overload), on the function of mitochondria and compared these effects on mitochondria isolated from low- and high-grade human brain tumors. Methods: Mitochondria were isolated from either low- or high-grade human primary brain tumors. Calcium overload conditions (100 or 200 μM), TMZ (300 μM), and BEV (2 mg/mL) were applied to isolated mitochondria from low- and high-grade brain tumors. Following the treatment, mitochondrial function, including reactive oxygen species production, membrane potential changes, and swelling, were determined. The mitochondrial morphology was also examined. Results: In calcium overload conditions, mitochondrial dysfunction was only found to have occurred in low-grade tumors. In TMZ and BEV treatment, BEV, rather than TMZ, caused greater membrane depolarization and mitochondrial swelling in both grades of brain tumors. Conclusions: TMZ and BEV can directly cause the dysfunction of mitochondria isolated from human brain tumors. However, BEV has a greater ability to disturb mitochondrial function in mitochondria isolated from human brain tumors than either TMZ or calcium overload conditions. … (more)
- Is Part Of:
- Neurological research. Volume 38:Number 4(2016)
- Journal:
- Neurological research
- Issue:
- Volume 38:Number 4(2016)
- Issue Display:
- Volume 38, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 38
- Issue:
- 4
- Issue Sort Value:
- 2016-0038-0004-0000
- Page Start:
- 285
- Page End:
- 293
- Publication Date:
- 2016-04-02
- Subjects:
- Human brain tumor -- Mitochondria -- Calcium overload -- Temozolomide and bevacizumab
Neurology -- Periodicals
Neurosciences -- Periodicals
616.8005 - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/3983345.html ↗
http://www.ingentaconnect.com/content/maney/nres ↗
http://www.maney.co.uk/search?fwaction=show&fwid=503 ↗
http://www.tandfonline.com/toc/yner20/current ↗
http://maneypublishing.com/ ↗ - DOI:
- 10.1080/01616412.2015.1114233 ↗
- Languages:
- English
- ISSNs:
- 0161-6412
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2914.xml